These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5634959)

  • 21. [Acute intermittent porphyria diagnosed by means of the analysis of porphyrins and their precursors in the urine. First case described in Costa Rica (author's transl)].
    Rojas Solano LF
    Sangre (Barc); 1978; 23(1):94-9. PubMed ID: 635733
    [No Abstract]   [Full Text] [Related]  

  • 22. [What is guaranteed in therapy of acute intermittent porphyria?].
    Ippen H; Fuchs T
    Internist (Berl); 1990 Nov; 31(11):698-701. PubMed ID: 2289855
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acute intermittent porphyria in the aged].
    Nielsen JK; Hansen OH
    Ugeskr Laeger; 1967 Nov; 129(47):1585-7. PubMed ID: 5592586
    [No Abstract]   [Full Text] [Related]  

  • 24. [Persistent arterial hypertensions in acute intermittent porphyria during treatment with ovulation inhibitors].
    Schley G; Bock KD; Werner U
    Verh Dtsch Ges Inn Med; 1975; 81():1061-3. PubMed ID: 1229398
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical medicine of disorders of porphyrin metabolism in man].
    Ghiringhelli P; Farfaglia P; Ghiringhelli L
    Minerva Med; 1987 Oct; 78(20):1495-517. PubMed ID: 3313115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of acute intermittent porphyria].
    Karazhanova LK; Ualieva TM
    Klin Med (Mosk); 1991 Sep; 69(9):82. PubMed ID: 1803165
    [No Abstract]   [Full Text] [Related]  

  • 27. [Gonadotropin and steroid hormone excretion during treatment with 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (mesterolone)].
    Laschet U; Laschet L; Paarmann HF
    Arzneimittelforschung; 1966 Apr; 16(4):469-71. PubMed ID: 6014252
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute intermittent porphyria].
    Papa B; Tadej D; Valentić V
    Lijec Vjesn; 1975 Jan; 97(1):33-7. PubMed ID: 1142978
    [No Abstract]   [Full Text] [Related]  

  • 29. [Acute intermittent porphyria versus porphyria variegata: a diagnostic uncertainty (author's transl)].
    Betancor León P; García Ruiz F; Font de Mora Turón A; López Martínez J; Schüller Pérez A
    Med Clin (Barc); 1980 Jan; 74(2):61-4. PubMed ID: 7366267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hereditary coproporphyria. A familial study].
    Rocchi E; Pietrangelo A; Gibertini P; Cassanelli M; Trenti T; Borghi A; Silingardi M; Jensen J; Ventura E
    Recenti Prog Med; 1984 Feb; 75(2):123-31. PubMed ID: 6729195
    [No Abstract]   [Full Text] [Related]  

  • 31. [Familial uroporphyrinuric pure late cutaneous porphyria].
    Degos R; de Cinarca OC; Méry F
    Bull Soc Fr Dermatol Syphiligr; 1970 Jul; 77(1):26-8. PubMed ID: 5430033
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical manifestations of acute intermittent porphyria (review of the literature)].
    Zakhariia EA; Temnik IV; Romanishin IaN
    Vrach Delo; 1986 Jan; (1):82-5. PubMed ID: 3953057
    [No Abstract]   [Full Text] [Related]  

  • 33. [Occupational aspects of porphyria cutanea tarda and the results of its treatment with anabolic steroid hormones].
    Paukert H
    Berufsdermatosen; 1965 Dec; 13(6):359-63. PubMed ID: 4223275
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neurologic manifestations of acute intermittent porphyria provoked by the use of barbiturates and estrogens (clinico-biochemical findings)].
    Popova VN; Tsyganova AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(4):541-4. PubMed ID: 5569419
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of acute porphyrias. The importance of follow-up of patients and carriers].
    Tasnádi G; Bor M; Pusztai A
    Orv Hetil; 2003 May; 144(19):933-8. PubMed ID: 12809070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute intermittent porphyria; a new case with acute rapidly fatal polyradiculoneuritis (author's transl)].
    Arnalich F; Enríquez de Salamanca S; Durán Pérez-Navarro A; García Puig J; Conthe P; Jusdado J; Gil A; Barbado FJ; Vázquez JJ
    Med Clin (Barc); 1981 Dec; 77(10):439-42. PubMed ID: 7329136
    [No Abstract]   [Full Text] [Related]  

  • 37. Faecal porphyrin excretion in various types of porphyria. Thin layer chromatographic study.
    Perrot H; Boucherat M; Thivolet J
    Arch Dermatol Res; 1978; 263(1):67-73. PubMed ID: 757459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities of the porphyrin metabolism in relatives of patients with acute porphyria.
    Mazza U; Massaro AL; Battistini V; Prato V
    Panminerva Med; 1966 Sep; 8(9):343-7. PubMed ID: 5925932
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hormone therapy of tumors in gynecology].
    Kaiser R
    Z Allgemeinmed; 1969 Mar; 45(7):301-8. PubMed ID: 5778600
    [No Abstract]   [Full Text] [Related]  

  • 40. Polypeptide levels increase during acute onset of hepatic porphyrias.
    Medenica R; Lazovic G; Huschart T; Mukerjee S; Long P; Corbitt W; Powell D
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):9-27. PubMed ID: 9074785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.